Palisade Historical Financial Ratios

PALI Stock

USD 0.71 0.01 1.07%

Palisade Bio is promptly reporting on over 93 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 5.55, Invested Capital of 0.0, Average Payables of 667.8 K or Stock Based Compensation To Revenue of 2.13 will help investors to properly organize and evaluate Palisade Bio financial condition quickly.

Quick Ratio Current Ratio

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Palisade Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.

About Palisade Financial Ratios Analysis

Palisade BioFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Palisade Bio investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Palisade financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Palisade Bio history.

Palisade Bio Financial Ratios Chart

As of now, Palisade Bio's EV To Operating Cash Flow is increasing as compared to previous years. The Palisade Bio's current EV To Free Cash Flow is estimated to increase to 0.64, while Price To Sales Ratio is projected to decrease to 13.80.

Price To Sales Ratio Days Sales Outstanding Average Payables Capex To Revenue

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Palisade Bio stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Palisade Bio sales, a figure that is much harder to manipulate than other Palisade Bio multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most ratios from Palisade Bio's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Palisade Bio current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Palisade Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.As of now, Palisade Bio's EV To Operating Cash Flow is increasing as compared to previous years. The Palisade Bio's current EV To Free Cash Flow is estimated to increase to 0.64, while Price To Sales Ratio is projected to decrease to 13.80.

	2024	2025 (projected)
Interest Debt Per Share	0.0551	0.0523
Revenue Per Share	0.63	0.6

Interest Debt Per Share Revenue Per Share

Palisade Bio fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow
Price To Sales Ratio		0.43	0.84	0.16	0.28	0.1	0.51	-0.27	0.43	1.0	0.1	0.06	0.15	0.1	-0.29	-0.45	0.99	-0.06	-0.64	0.15	-0.38	-0.65	-0.42	-0.15	-0.13	-0.64
Ptb Ratio	0.43		0.12	0.22	0.41	0.15	0.75	-0.14	1.0	0.43	0.15	-0.43	0.22	0.16	-0.42	-0.68	0.45	-0.14	-0.72	-0.59	-0.85	-0.72	-0.63	-0.19	-0.64	-0.72
Days Sales Outstanding	0.84	0.12		0.2	0.27	0.16	0.34	-0.15	0.12	0.84	0.16	0.18	0.15	0.16	-0.28	-0.29	0.83	-0.12	-0.5	0.21	-0.21	-0.5	-0.19	-0.2	0.08	-0.5
Book Value Per Share	0.16	0.22	0.2		-0.13	1.0	0.43	0.31	0.22	0.16	1.0	-0.62	-0.08	1.0	0.14	-0.29	0.17	-0.99	-0.2	-0.09	0.09	-0.2	-0.32	0.3	-0.62	-0.2
Free Cash Flow Yield	0.28	0.41	0.27	-0.13		-0.18	0.54	-0.53	0.41	0.28	-0.18	0.13	0.15	-0.17	-0.71	-0.61	0.31	0.19	-0.38	-0.27	-0.46	-0.38	-0.34	-0.03	0.01	-0.38
Operating Cash Flow Per Share	0.1	0.15	0.16	1.0	-0.18		0.35	0.35	0.15	0.1	1.0	-0.61	-0.08	1.0	0.18	-0.22	0.1	-1.0	-0.12	-0.07	0.16	-0.12	-0.25	0.32	-0.6	-0.12
Average Payables	0.51	0.75	0.34	0.43	0.54	0.35		-0.39	0.75	0.51	0.35	-0.33	0.24	0.37	-0.5	-0.88	0.55	-0.33	-0.66	-0.35	-0.63	-0.66	-0.81	-0.06	-0.52	-0.66
Capex To Depreciation	-0.27	-0.14	-0.15	0.31	-0.53	0.35	-0.39		-0.14	-0.27	0.35	-0.25	-0.32	0.34	0.58	0.67	-0.31	-0.36	0.16	-0.07	0.19	0.17	0.62	-0.26	-0.19	0.16
Pb Ratio	0.43	1.0	0.12	0.22	0.41	0.15	0.75	-0.14		0.43	0.15	-0.43	0.22	0.16	-0.42	-0.68	0.45	-0.14	-0.72	-0.59	-0.85	-0.72	-0.63	-0.19	-0.64	-0.72
Ev To Sales	1.0	0.43	0.84	0.16	0.28	0.1	0.51	-0.27	0.43		0.1	0.06	0.15	0.1	-0.29	-0.45	0.99	-0.06	-0.64	0.15	-0.38	-0.65	-0.42	-0.15	-0.13	-0.64
Free Cash Flow Per Share	0.1	0.15	0.16	1.0	-0.18	1.0	0.35	0.35	0.15	0.1		-0.61	-0.08	1.0	0.18	-0.22	0.1	-1.0	-0.12	-0.07	0.16	-0.12	-0.25	0.32	-0.6	-0.12
Roic	0.06	-0.43	0.18	-0.62	0.13	-0.61	-0.33	-0.25	-0.43	0.06	-0.61		0.29	-0.61	-0.27	0.27	0.04	0.63	0.03	0.65	0.2	0.03	0.4	-0.24	0.93	0.03
Inventory Turnover	0.15	0.22	0.15	-0.08	0.15	-0.08	0.24	-0.32	0.22	0.15	-0.08	0.29		-0.08	-0.78	-0.34	0.16	0.09	-0.2	-0.11	-0.24	-0.2	-0.13	0.2	0.22	-0.2
Net Income Per Share	0.1	0.16	0.16	1.0	-0.17	1.0	0.37	0.34	0.16	0.1	1.0	-0.61	-0.08		0.17	-0.24	0.11	-1.0	-0.13	-0.08	0.15	-0.13	-0.26	0.32	-0.6	-0.13
Days Of Inventory On Hand	-0.29	-0.42	-0.28	0.14	-0.71	0.18	-0.5	0.58	-0.42	-0.29	0.18	-0.27	-0.78	0.17		0.64	-0.31	-0.19	0.39	0.23	0.47	0.39	0.32	-0.08	-0.14	0.39
Payables Turnover	-0.45	-0.68	-0.29	-0.29	-0.61	-0.22	-0.88	0.67	-0.68	-0.45	-0.22	0.27	-0.34	-0.24	0.64		-0.49	0.2	0.6	0.32	0.59	0.61	0.92	-0.23	0.39	0.6
Capex To Revenue	0.99	0.45	0.83	0.17	0.31	0.1	0.55	-0.31	0.45	0.99	0.1	0.04	0.16	0.11	-0.31	-0.49		-0.07	-0.62	0.13	-0.38	-0.63	-0.45	-0.15	-0.16	-0.62
Cash Per Share	-0.06	-0.14	-0.12	-0.99	0.19	-1.0	-0.33	-0.36	-0.14	-0.06	-1.0	0.63	0.09	-1.0	-0.19	0.2	-0.07		0.07	0.09	-0.18	0.07	0.23	-0.34	0.61	0.07
Pocfratio	-0.64	-0.72	-0.5	-0.2	-0.38	-0.12	-0.66	0.16	-0.72	-0.64	-0.12	0.03	-0.2	-0.13	0.39	0.6	-0.62	0.07		0.09	0.8	1.0	0.55	0.31	0.18	1.0
Interest Coverage	0.15	-0.59	0.21	-0.09	-0.27	-0.07	-0.35	-0.07	-0.59	0.15	-0.07	0.65	-0.11	-0.08	0.23	0.32	0.13	0.09	0.09		0.58	0.08	0.27	0.01	0.62	0.09
Capex To Operating Cash Flow	-0.38	-0.85	-0.21	0.09	-0.46	0.16	-0.63	0.19	-0.85	-0.38	0.16	0.2	-0.24	0.15	0.47	0.59	-0.38	-0.18	0.8	0.58		0.8	0.53	0.4	0.32	0.8
Pfcf Ratio	-0.65	-0.72	-0.5	-0.2	-0.38	-0.12	-0.66	0.17	-0.72	-0.65	-0.12	0.03	-0.2	-0.13	0.39	0.61	-0.63	0.07	1.0	0.08	0.8		0.56	0.31	0.18	1.0
Days Payables Outstanding	-0.42	-0.63	-0.19	-0.32	-0.34	-0.25	-0.81	0.62	-0.63	-0.42	-0.25	0.4	-0.13	-0.26	0.32	0.92	-0.45	0.23	0.55	0.27	0.53	0.56		-0.23	0.48	0.55
Income Quality	-0.15	-0.19	-0.2	0.3	-0.03	0.32	-0.06	-0.26	-0.19	-0.15	0.32	-0.24	0.2	0.32	-0.08	-0.23	-0.15	-0.34	0.31	0.01	0.4	0.31	-0.23		-0.07	0.31
Roe	-0.13	-0.64	0.08	-0.62	0.01	-0.6	-0.52	-0.19	-0.64	-0.13	-0.6	0.93	0.22	-0.6	-0.14	0.39	-0.16	0.61	0.18	0.62	0.32	0.18	0.48	-0.07		0.18
Ev To Operating Cash Flow	-0.64	-0.72	-0.5	-0.2	-0.38	-0.12	-0.66	0.16	-0.72	-0.64	-0.12	0.03	-0.2	-0.13	0.39	0.6	-0.62	0.07	1.0	0.09	0.8	1.0	0.55	0.31	0.18

Click cells to compare fundamentals

Palisade Bio Account Relationship Matchups

Palisade Bio fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	2.0K	10.9K	16.3K	16.14	14.53	13.8
Ptb Ratio	(13.23)	1.38	0.37	0.36	0.31	0.3
Days Sales Outstanding	502.57	499.44	1.6K	216.08	248.49	236.07
Book Value Per Share	(299.21)	704.58	212.69	24.81	5.29	5.55
Free Cash Flow Yield	(0.0217)	(1.45)	(2.92)	(2.76)	(5.22)	(4.96)
Operating Cash Flow Per Share	(85.93)	(1.4K)	(227.7)	(24.41)	(8.61)	(9.04)
Stock Based Compensation To Revenue	4.19	215.99	148.96	2.5	2.25	2.13
Pb Ratio	(13.23)	1.38	0.37	0.36	0.31	0.3
Ev To Sales	2.0K	10.6K	16.3K	(32.11)	(28.9)	(27.45)
Free Cash Flow Per Share	(86.04)	(1.4K)	(227.87)	(24.42)	(8.61)	(9.04)
Roic	2.47	(4.15)	(1.09)	(1.11)	(1.92)	(2.02)
Net Income Per Share	(190.5)	(2.6K)	(218.14)	(26.97)	(10.19)	(10.7)
Sales General And Administrative To Revenue	13.72	472.39	458.43	24.81	22.33	21.21
Research And Ddevelopement To Revenue	15.23	263.83	229.22	27.57	24.81	23.57
Cash Per Share	13.14	1.0K	211.05	27.26	6.93	6.59
Pocfratio	(46.08)	(0.69)	(0.34)	(0.36)	(0.19)	(0.2)
Interest Coverage	(39.56)	(17.45)	(1.2K)	(871.33)	1.2K	1.3K
Pfcf Ratio	(46.02)	(0.69)	(0.34)	(0.36)	(0.19)	(0.2)
Income Quality	1.56	0.87	0.46	0.56	0.94	0.6
Roe	0.64	(3.7)	(1.03)	(1.09)	(1.93)	(2.02)
Ev To Operating Cash Flow	(46.23)	0.007062	0.55	0.72	0.61	0.64
Pe Ratio	(20.79)	(0.37)	(0.36)	(0.33)	(0.16)	(0.17)
Return On Tangible Assets	(3.5)	(2.18)	(0.81)	(0.88)	(1.33)	(1.39)
Ev To Free Cash Flow	(46.17)	0.007062	0.55	0.72	0.61	0.64
Earnings Yield	(0.0481)	(2.68)	(2.8)	(3.05)	(6.18)	(5.87)
Net Debt To E B I T D A	(0.0712)	0.43	0.78	0.98	0.65	0.37
Current Ratio	0.11	4.96	4.89	5.15	3.24	3.21
Tangible Book Value Per Share	(299.21)	704.58	212.69	24.81	5.29	5.55
Shareholders Equity Per Share	(299.21)	704.58	212.69	24.81	5.29	5.55
Debt To Equity	(0.0856)	0.027	0.0324	0.0326	0.012	0.0114

Currently Active Assets on Macroaxis

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria
HMY	Harmony Gold Mining
FSM	Fortuna Silver Mines

When determining whether Palisade Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Palisade Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Palisade Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Palisade Bio Stock:

How To Invest In Palisade

Details

Is Palisade Stock a good investment?

Details

What is Palisade Bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.

You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palisade Bio. If investors know Palisade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(13.26)

Return On Assets

(0.68)

Return On Equity

(1.36)

The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Palisade Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Palisade Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palisade Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Shareholders Equity Per Share	Debt To Equity
Capex Per Share	Graham Net Net
Average Receivables	Revenue Per Share
Interest Debt Per Share	Debt To Assets
Enterprise Value Over E B I T D A	Short Term Coverage Ratios
Price Earnings Ratio	Operating Cycle
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Cash Conversion Cycle	Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding	Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio	Cash Flow Coverage Ratios
Price To Book Ratio	Fixed Asset Turnover
Capital Expenditure Coverage Ratio	Price Cash Flow Ratio
Enterprise Value Multiple	Debt Ratio
Cash Flow To Debt Ratio	Price Sales Ratio
Return On Assets	Asset Turnover
Net Profit Margin	Gross Profit Margin
Price Fair Value	Return On Equity

Palisade Historical Financial Ratios

About Palisade Financial Ratios Analysis

Palisade Bio Financial Ratios Chart

Price To Sales Ratio

Average Payables

Capex To Revenue

Palisade Bio fundamentals Correlations

Palisade Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Palisade Bio fundamentals Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Operating Cash Flow Per Share	+ 1.0	Book Value Per Share
Free Cash Flow Per Share	+ 1.0	Book Value Per Share
Net Income Per Share	+ 1.0	Book Value Per Share
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share

Cash Per Share	- 1.0	Net Income Per Share
Cash Per Share	- 1.0	Free Cash Flow Per Share
Cash Per Share	- 1.0	Operating Cash Flow Per Share
Cash Per Share	- 0.99	Book Value Per Share
Payables Turnover	- 0.88	Average Payables
Capex To Operating Cash Flow	- 0.85	Pb Ratio